Wiskott-Aldrich Syndrome: Another Piece in the Puzzle

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2005 Jan 19

PMID 15654814

Citations 2

Authors

L D Notarangelo

L Mori

Affiliations

Soon will be listed here.

Citing Articles

Diversity of polyproline recognition by EVH1 domains.

Peterson F, Volkman B Front Biosci (Landmark Ed). 2009; 14(3):833-46.

PMID: 19273103 PMC: 3882067. DOI: 10.2741/3281.

[Associated diseases and differential diagnostic considerations in childhood atopic eczema].

Jenneck C, Foelster-Holst R, Hagemann T, Novak N Hautarzt. 2007; 58(2):163-74.

PMID: 17268788 DOI: 10.1007/s00105-006-1279-4.

References

Burns S, Hardy S, Buddle J, Yong K, Jones G, Thrasher A . Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton. 2003; 57(2):118-32. DOI: 10.1002/cm.10163. View

Vermi W, Blanzuoli L, Kraus M, Grigolato P, Donato F, Loffredo G . The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol. 1999; 23(2):182-91. DOI: 10.1097/00000478-199902000-00007. View

Park J, Kob M, Prodeus A, Rosen F, Shcherbina A, Remold-ODonnell E . Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol. 2004; 136(1):104-10. PMC: 1809006. DOI: 10.1111/j.1365-2249.2004.02409.x. View

Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S . Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 2004; 104(2):436-43. DOI: 10.1182/blood-2003-07-2621. View

Gulino A, Moratto D, Sozzani S, Cavadini P, Otero K, Tassone L . Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood. 2004; 104(2):444-52. DOI: 10.1182/blood-2003-10-3532. View

Allen C, Ansel K, Low C, Lesley R, Tamamura H, Fujii N . Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004; 5(9):943-52. DOI: 10.1038/ni1100. View

Cooper M, Chae H, LOWMAN J, Krivit W, GOOD R . Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med. 1968; 44(4):499-513. DOI: 10.1016/0002-9343(68)90051-x. View

Molina I, Kenney D, Rosen F, Remold-ODonnell E . T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med. 1992; 176(3):867-74. PMC: 2119357. DOI: 10.1084/jem.176.3.867. View

Derry J, Ochs H, Francke U . Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994; 78(4):635-44. DOI: 10.1016/0092-8674(94)90528-2. View

10.

Linder S, Nelson D, Weiss M, Aepfelbacher M . Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A. 1999; 96(17):9648-53. PMC: 22264. DOI: 10.1073/pnas.96.17.9648. View

11.

Burns S, Cory G, Vainchenker W, Thrasher A . Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004; 104(12):3454-62. DOI: 10.1182/blood-2004-04-1678. View

12.

Jin Y, Mazza C, Christie J, Giliani S, Fiorini M, Mella P . Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004; 104(13):4010-9. DOI: 10.1182/blood-2003-05-1592. View

13.

Park J, Shcherbina A, Rosen F, Prodeus A, Remold-ODonnell E . Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol. 2005; 139(2):297-305. PMC: 1809280. DOI: 10.1111/j.1365-2249.2005.02693.x. View

14.

Westerberg L, Larsson M, Hardy S, Fernandez C, Thrasher A, Severinson E . Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2004; 105(3):1144-52. DOI: 10.1182/blood-2004-03-1003. View

15.

De Noronha S, Hardy S, Sinclair J, Blundell M, Strid J, Schulz O . Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood. 2004; 105(4):1590-7. DOI: 10.1182/blood-2004-06-2332. View

16.

Filipovich A, Stone J, Tomany S, Ireland M, Kollman C, Pelz C . Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001; 97(6):1598-603. DOI: 10.1182/blood.v97.6.1598. View

17.

Devriendt K, Kim A, Mathijs G, Frints S, Schwartz M, van den Oord J . Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001; 27(3):313-7. DOI: 10.1038/85886. View

18.

Burns S, Thrasher A, Blundell M, Machesky L, Jones G . Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood. 2001; 98(4):1142-9. DOI: 10.1182/blood.v98.4.1142. View

19.

Notarangelo L, Mazza C, Giliani S, DAria C, Gandellini F, Ravelli C . Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 2002; 99(6):2268-9. DOI: 10.1182/blood.v99.6.2268. View

20.

Orange J, Ramesh N, Remold-ODonnell E, Sasahara Y, Koopman L, Byrne M . Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002; 99(17):11351-6. PMC: 123260. DOI: 10.1073/pnas.162376099. View